144 related articles for article (PubMed ID: 12587794)
1. Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors.
Newton HB; Slivka MA; Volpi C; Bourekas EC; Christoforidis GA; Baujan MA; Slone W; Chakeres DW
J Neurooncol; 2003 Jan; 61(1):35-44. PubMed ID: 12587794
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
Newton HB; Slivka MA; Stevens CL; Bourekas EC; Christoforidis GA; Baujan MA; Chakeres DW
J Neurooncol; 2002 Jan; 56(1):79-86. PubMed ID: 11949830
[TBL] [Abstract][Full Text] [Related]
3. Brain metastases from fallopian tube carcinoma responsive to intra-arterial carboplatin and intravenous etoposide: a case report.
Newton HB; Stevens C; Santi M
J Neurooncol; 2001 Dec; 55(3):179-84. PubMed ID: 11859973
[TBL] [Abstract][Full Text] [Related]
4. Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
Urban C; Benesch M; Pakisch B; Lackner H; Kerbl R; Schwinger W; Oberbauer R
J Neurooncol; 1998 Aug; 39(1):71-80. PubMed ID: 9760072
[TBL] [Abstract][Full Text] [Related]
5. Unusual cervical spinal cord toxicity associated with intra-arterial carboplatin, intra-arterial or intravenous etoposide phosphate, and intravenous cyclophosphamide in conjunction with osmotic blood brain-barrier disruption in the vertebral artery.
Fortin D; McAllister LD; Nesbit G; Doolittle ND; Miner M; Hanson EJ; Neuwelt EA
AJNR Am J Neuroradiol; 1999; 20(10):1794-802. PubMed ID: 10588099
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.
Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D
Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659
[TBL] [Abstract][Full Text] [Related]
7. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
9. Response of brain metastases from lung cancer to systemic chemotherapy with carboplatin and etoposide.
Malacarne P; Santini A; Maestri A
Oncology; 1996; 53(3):210-3. PubMed ID: 8643223
[TBL] [Abstract][Full Text] [Related]
10. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
[TBL] [Abstract][Full Text] [Related]
11. Attempted dose intensified cyclophosphamide, etoposide, and granulocyte colony-stimulating factor for treatment of malignant astrocytoma.
Newton HB; Newton CL
J Neurooncol; 1995; 24(3):285-92. PubMed ID: 7595759
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer.
Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
J Natl Cancer Inst; 2003 Aug; 95(15):1118-27. PubMed ID: 12902441
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
Scagliotti GV; Ricardi U; Crinó L; Maranzano E; De Marinis F; Morandi MG; Meacci L; Marangolo M; Emiliani E; Rosti G; Figoli F; Bolzicco G; Masiero P; Gentile A; Tonato M
Cancer Chemother Pharmacol; 1996; 38(6):561-5. PubMed ID: 8823499
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and rupture rate of cerebral aneurysms discovered during intra-arterial chemotherapy of brain tumors.
Bourekas EC; Newton HB; Figg GM; Slone HW
AJNR Am J Neuroradiol; 2006 Feb; 27(2):297-9. PubMed ID: 16484396
[TBL] [Abstract][Full Text] [Related]
16. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
Comella P; Scoppa G; Daponte A; Musetta G; Anania C; Maiorino A; Curcio C; Casaretti R; Comella G
Cancer; 1994 Oct; 74(7):1874-81. PubMed ID: 8082093
[TBL] [Abstract][Full Text] [Related]
17. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer.
Miller AA; Al Omari A; Murry DJ; Case D
Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403
[TBL] [Abstract][Full Text] [Related]
18. Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors.
Madajewicz S; Chowhan N; Iliya A; Roque C; Beaton R; Davis R; Fertman S; Meek A; Alvarez O; Pampati M
Cancer; 1991 Jun; 67(11):2844-9. PubMed ID: 1851050
[TBL] [Abstract][Full Text] [Related]
19. Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study.
Ashby LS; Shapiro WR
J Neurooncol; 2001 Jan; 51(1):67-86. PubMed ID: 11349883
[TBL] [Abstract][Full Text] [Related]
20. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]